SCHEMBL10189500

SCHEMBL10189500

CCNc1sc2c(c1C(=O)N1CCCC1)CCN(CC)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 10/20 0.51
▸ MAPT P10636 7/20 0.51
▸ MEN1 O00255 5/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ HPGD P15428 3/20 0.51
▸ GAA P10253 3/20 0.51
▸ KCNH2 Q12809 2/20 0.47
▸ MITF O75030 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ USP2 O75604 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ PKM P14618 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ GPR55 Q9Y2T6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10190438 0.86 KMT2A (0.49) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10190437 0.84 KMT2A (0.68) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10189645 0.83 L3MBTL1 (0.62) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL16962841 0.77 ALDH1A1 (0.55) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL17018756 0.73 ALDH1A1 (0.55) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL16962878 0.73 KCNH2 (0.71) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL18902090 0.73 KMT2A (0.70) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL13151110 0.73 PTPN2 (0.53) KMT2AMAPTMEN1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL16962172 0.72 KCNH2 (0.71) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL16962118 0.71 ALDH1A1 (0.67) KMT2AMAPTMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329907-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2012-12-11 — — US disclosed
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 KMT2A 1523/4885MAPT 2648/4885MEN1 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback